{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:12:10Z","timestamp":1791331930311,"version":"4.3.1"},"reference-count":49,"publisher":"Impact Journals, LLC","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2014,9,30]]},"DOI":"10.18632\/oncotarget.2340","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T23:38:12Z","timestamp":1442360292000},"page":"8188-8201","source":"Crossref","is-referenced-by-count":27,"title":["Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells"],"prefix":"10.18632","volume":"5","author":[{"given":"Hao","family":"Yang","sequence":"first","affiliation":[{"name":"State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Hui","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zhou","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu Province, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Florida International University, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidong","family":"You","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglong","family":"Guo","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Lu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2014,8,10]]},"reference":[{"issue":"3","key":"1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome","volume":"45","author":"Lozzio","year":"1975","journal-title":"Blood"},{"issue":"3","key":"2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pharmthera.2003.09.002","article-title":"Mechanisms involved in the induced differentiation of leukemia cells","volume":"100","author":"Vizirianakis","year":"2003","journal-title":"Pharmacol Ther"},{"issue":"6","key":"3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Barnes","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Barnes","year":"2007","journal-title":"Nature Reviews Cancer"},{"issue":"9","key":"5","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s10495-013-0854-2","article-title":"Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-\u03baB inhibition and Bcr\/Abl protein deletion","volume":"18","author":"Yan","year":"2013","journal-title":"Apoptosis"},{"issue":"11","key":"6","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1182\/blood.V95.11.3498","article-title":"Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR\/ABL-transformed hematopoietic cell lines","volume":"95","author":"Griffin","year":"2000","journal-title":"Blood"},{"issue":"1","key":"7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1054\/drup.2000.0176","article-title":"Mechanisms of resistance to imatinib (STI571) and prospects for combination with conventional chemotherapeutic agents","volume":"4","author":"Krystal","year":"2001","journal-title":"Drug Resist Updat"},{"issue":"5531","key":"8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Sawyers","year":"2001","journal-title":"Science"},{"issue":"4","key":"9","first-page":"484","article-title":"Kinase-addiction and bi-phasic sensitivity-resistance of Bcr-Abl- and Raf-1-expressing cells to imatinib and geldanamycin","volume":"4","author":"Blagosklonny","year":"2005","journal-title":"Cancer Biol Ther"},{"issue":"7","key":"10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/leu.2011.67","article-title":"The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem\/progenitor cells","volume":"25","author":"Holyoake","year":"2011","journal-title":"Leukemia"},{"issue":"7","key":"11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/leu.2011.67","article-title":"The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem\/progenitor cells","volume":"25","author":"Holyoake","year":"2011","journal-title":"Leukemia"},{"issue":"10","key":"12","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.leu.2402257","article-title":"The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy","volume":"15","author":"Neckers","year":"2001","journal-title":"Leukemia"},{"issue":"3","key":"13","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1128\/MCB.17.3.1642","article-title":"Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line","volume":"17","author":"Orkin","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"1","key":"14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcdb.2004.11.002","article-title":"GATA1 in normal and malignant hematopoiesis","volume":"16","author":"Crispino","year":"2005","journal-title":"Semin Cell Dev Biol"},{"issue":"15","key":"15","doi-asserted-by":"crossref","first-page":"8811","DOI":"10.1073\/pnas.1432147100","article-title":"GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling","volume":"100","author":"Bresnick","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1073\/pnas.0306315101","article-title":"Context-dependent regulation of GATA-1 by friend of GATA-1","volume":"101","author":"Blobel","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2302\/kjm.60.47","article-title":"Role of transcription factors in differentiation and reprogramming of hematopoietic cells","volume":"60","author":"Nakajima","year":"2011","journal-title":"Keio J Med"},{"issue":"6306","key":"18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/349257a0","article-title":"Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1","volume":"349","author":"Costantini","year":"1991","journal-title":"Nature"},{"issue":"22","key":"19","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1073\/pnas.93.22.12355","article-title":"Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1","volume":"93","author":"Orkin","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"20","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.molcel.2012.05.051","article-title":"Cofactor-mediated restriction of GATA-1 chromatin occupancy coordinates lineage-specific gene expression","volume":"47","author":"Crispino","year":"2012","journal-title":"Mol Cell"},{"key":"21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2008.06.024","article-title":"Wogonin induced differentiation and G1 phase arrest of human U-937 leukemia cells via PKC\u03b4 phosphorylation","volume":"591","author":"Guo","year":"2008","journal-title":"European Journal of Pharmacology"},{"issue":"4","key":"22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1349-7006.2008.00728.x","article-title":"Wogonin induces the granulocytic differentiation of human NB4 promyelocytic leukemia cells and up-regulates phospholipid scramblase 1 gene expression","volume":"99","author":"Wang","year":"2008","journal-title":"Cancer Science"},{"issue":"8","key":"23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.cdd.4400400","article-title":"Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR - ABL tyrosine kinase, CGP 57148","volume":"5","author":"Tsuruo","year":"1998","journal-title":"Cell Death Differ"},{"issue":"14","key":"24","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Sawyers","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/emboj.2009.336","article-title":"NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development","volume":"29","author":"Blobel","year":"2010","journal-title":"EMBO J"},{"issue":"3","key":"26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1182\/blood.V80.3.575.575","article-title":"GATA-binding transcription factors in hematopoietic cells","volume":"80","author":"Orkin","year":"1992","journal-title":"Blood"},{"issue":"1","key":"27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.semcdb.2004.10.006","article-title":"Coregulation of GATA factors by the Friend of GATA (FOG) family of multitype zinc finger proteins","volume":"16","author":"Orkin","year":"2005","journal-title":"Semin Cell Dev Biol"},{"issue":"13","key":"28","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1038\/sj.emboj.7600703","article-title":"FOG-1 recruits the NuRD repressor complex to mediate transcriptional repression by GATA-1","volume":"24","author":"Blobel","year":"2005","journal-title":"EMBO J"},{"issue":"10","key":"29","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.4161\/cc.9.10.11602","article-title":"GATA-1 directly regulates p21 gene expression during erythroid differentiation","volume":"9","author":"Skoultchi","year":"2010","journal-title":"Cell Cycle"},{"issue":"26","key":"30","doi-asserted-by":"crossref","first-page":"14317","DOI":"10.1073\/pnas.250488697","article-title":"Reprogramming leukemic cells to terminal differentiation by inhibiting specific cyclin-dependent kinases in G1","volume":"97","author":"Skoultchi","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"31","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1073\/pnas.85.16.5976","article-title":"An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes","volume":"85","author":"Felsenfeld","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"32","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1101\/gr.083089.108","article-title":"Transcriptional enhancement by GATA1-occupied DNA segments is strongly associated with evolutionary constraint on the binding site motif","volume":"18","author":"Hardison","year":"2008","journal-title":"Genome Res"},{"issue":"8","key":"33","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1-positive chronic myeloid leukemia","volume":"113","author":"Cortes","year":"2009","journal-title":"Blood"},{"issue":"3","key":"34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"41","key":"35","doi-asserted-by":"crossref","first-page":"31774","DOI":"10.1074\/jbc.M110.118653","article-title":"BCR-ABL but not JAK2 V617F inhibits erythropoiesis through the Ras signal by inducing p21CIP1\/WAF1","volume":"285","author":"Kanakura","year":"2010","journal-title":"J Biol Chem"},{"issue":"2","key":"36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/MOH.0b013e3283257aee","article-title":"Differentiation therapy of acute myeloid leukemia: past, present and future","volume":"16","author":"Waxman","year":"2009","journal-title":"Curr Opin Hematol"},{"issue":"11","key":"37","first-page":"629","article-title":"Valproic acid and all-trans retinoic acid: meta-analysis of a palliative treatment regimen in AML and MDS patients","volume":"31","author":"Mahlknecht","year":"2008","journal-title":"Onkologie"},{"issue":"5","key":"38","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1182\/blood-2009-03-207944","article-title":"Graded repression of PU. 1\/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate","volume":"114","author":"Weiss","year":"2009","journal-title":"Blood"},{"issue":"14","key":"39","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1128\/MCB.23.14.5031-5042.2003","article-title":"GATA-1-mediated proliferation arrest during erythroid maturation","volume":"23","author":"Weiss","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"8","key":"40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/iub.226","article-title":"Erythropoiesis: model systems, molecular regulators, and developmental programs","volume":"61","author":"Strouboulis","year":"2009","journal-title":"IUBMB Life"},{"issue":"13","key":"41","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1093\/nar\/gks281","article-title":"Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies","volume":"40","author":"Perkins","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"42","article-title":"Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1alpha and glycolysis, by inhibiting PI3K\/Akt signaling pathway","author":"Guo","year":"2013","journal-title":"Mol Carcinog"},{"key":"43","article-title":"Nuclear translocation of mitogen-activated protein kinase kinase (MEK1) in response to mitogenic stimulation","author":"Seger","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"44","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1056\/NEJMoa1002315","article-title":"Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia","volume":"362","author":"Kantarjian","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/00304940903102739","article-title":"Convenient Synthesis of Wogonin, A Flavonoid Natural Product with Extensive Pharmacological Activity","volume":"41","author":"You","year":"2009","journal-title":"Organic Preparations and Procedures International"},{"issue":"6","key":"46","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1159\/000323973","article-title":"p38 MAPK contributes to the growth inhibition of leukemic tumor cells mediated by human umbilical cord mesenchymal stem cells","volume":"26","author":"Zhang","year":"2010","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood-2009-09-241778","article-title":"HSP27 controls GATA-1 protein level during erythroid cell differentiation","volume":"116","author":"Garrido","year":"2010","journal-title":"Blood"},{"issue":"18","key":"48","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood-2012-11-466219","article-title":"Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PLSCR1 in AML cells","volume":"121","author":"Guo","year":"2013","journal-title":"Blood"},{"issue":"12","key":"49","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1349-7006.2006.00340.x","article-title":"Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro","volume":"97","author":"Qiu","year":"2006","journal-title":"Cancer Sci"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T20:55:58Z","timestamp":1589403358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,10]]},"references-count":49,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2014,9,30]]}},"alternative-id":["2340","25149543"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.2340","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,10]]}}}